Atorvastatin vs simvastatin side effects
Pro Research Analysisby 
Searched over 200M research papers
Comparative Analysis of Atorvastatin vs. Simvastatin Side Effects
Introduction to Statins and Their Use
Statins, including atorvastatin and simvastatin, are widely prescribed for lowering low-density lipoprotein (LDL) cholesterol to reduce cardiovascular risk. Both drugs are effective, but their side effect profiles can differ, which is crucial for patient management.
General Safety and Tolerability
Adverse Event Rates
Both atorvastatin and simvastatin have been shown to be generally well-tolerated. In a study involving 3,748 coronary heart disease (CHD) patients, adverse event rates were statistically equivalent for simvastatin (35.7%) and atorvastatin (36.3%) 1. Similarly, another study found that side effects were noted in 10-36% of patients, with one case of rhabdomyolysis reported 2.
Serious Adverse Events
Serious adverse events were relatively rare for both drugs. In the TARGET TANGIBLE trial, 2% of atorvastatin patients and 3% of simvastatin patients experienced serious adverse events 1. Another study reported that no serious adverse events were considered associated with treatment in either group 10.
Specific Side Effects
Liver Enzyme Elevations
Elevations in liver enzymes, such as alanine aminotransferase (ALT) and aspartate aminotransferase (AST), were observed in both treatment groups. However, significantly fewer patients treated with simvastatin experienced these elevations compared to those treated with atorvastatin (0.4% vs. 2.8%) 5.
Muscle-Related Side Effects
Both drugs can cause muscle-related side effects, including myalgia and, in rare cases, rhabdomyolysis. In a study comparing high doses of both drugs, gastrointestinal side effects were more common with atorvastatin, while simvastatin had fewer muscle-related issues 4.
Impact on Lipid Profiles
LDL and HDL Cholesterol
Atorvastatin generally shows a greater reduction in LDL cholesterol compared to simvastatin. For instance, atorvastatin 10 mg reduced LDL cholesterol by 37%, which was more effective than simvastatin 20 mg (33.8%) 8. However, simvastatin was more effective in raising high-density lipoprotein (HDL) cholesterol and apolipoprotein A-I levels 69.
Triglycerides
Both statins effectively reduce triglycerides, but atorvastatin has shown a slightly superior effect in some studies 6.
Special Populations
Older Adults
In older adults (≥65 years), the safety profiles of both drugs were similar, although adherence was lower in older patients and those receiving atorvastatin 7.
Familial Hypercholesterolemia
In patients with familial hypercholesterolemia, atorvastatin was more effective in achieving LDL targets but was associated with a possible increase in side effects 24.
Conclusion
Both atorvastatin and simvastatin are effective and generally well-tolerated for lowering LDL cholesterol. However, atorvastatin may be associated with a higher incidence of liver enzyme elevations and gastrointestinal side effects, while simvastatin may have a more favorable profile for raising HDL cholesterol and fewer muscle-related side effects. The choice between these statins should be individualized based on patient-specific factors, including the lipid profile and tolerance to side effects.
Sources and full results
Most relevant research papers on this topic
Safety of low-density lipoprotein cholestrol reduction with atorvastatin versus simvastatin in a coronary heart disease population (the TARGET TANGIBLE trial).
Both atorvastatin and simvastatin are safe for use in secondary prevention of coronary heart disease, with similar adverse event rates and no drug-induced rhabdomyolysis.
RCT
Large Human TrialAtorvastatin compared with simvastatin-based therapies in the management of severe familial hyperlipidaemias.
Atorvastatin is more effective than simvastatin-based therapies in achieving treatment targets for patients with familial hypercholesterolaemia, but may increase side-effects.
Observational StudySimvastatin versus atorvastatin for improving mild to moderate depression in post-coronary artery bypass graft patients: A double-blind, placebo-controlled, randomized trial.
Simvastatin shows superior antidepressant effects compared to atorvastatin in post-coronary artery bypass graft patients, with no significant difference in adverse events.
RCT
Rigorous JournalCOMPARISON OF THERAPY WITH SIMVASTATIN 80 MG AND ATORVASTATIN 80 MG IN PATIENTS WITH FAMILIAL HYPERCHOLESTEROLAEMIA
Simvastatin is more effective in raising HDL and causing fewer side-effects than atorvastatin in treating familial hypercholesterolaemia.
Non-RCTEffect on high-density lipoprotein cholesterol of maximum dose simvastatin and atorvastatin in patients with hypercholesterolemia: results of the Comparative HDL Efficacy and Safety Study (CHESS).
Simvastatin (80 mg) significantly increased HDL-C and apo A-I levels more than atorvastatin (80 mg) in patients with hypercholesterolemia, with fewer episodes of elevated liver enzymes.
RCTLarge Human Trial
Highly CitedDose-response effects of atorvastatin and simvastatin on high-density lipoprotein cholesterol in hypercholesterolaemic patients: a review of five comparative studies.
At higher doses, simvastatin increases HDL-C and Apo A-I more than atorvastatin, suggesting that statins may not be identical in their clinical properties related to reducing atherosclerosis risks.
Systematic ReviewComparison of efficacy and safety of atorvastatin (80 mg) to simvastatin (20 to 40 mg) in patients aged <65 versus >or=65 years with coronary heart disease (from the Incremental DEcrease through Aggressive Lipid Lowering [IDEAL] study).
Atorvastatin (80 mg) is more effective in reducing cardiovascular events in patients aged 65 years compared to simvastatin (20 to 40 mg) in both 65 and >65 years with stable coronary disease.
RCTLarge Human TrialEfficacy of Atorvastatin Compared With Simvastatin in Patients With Hypercholesterolemia
Atorvastatin 10 mg is more effective than simvastatin 20 mg and significantly more effective than simvastatin 10 mg for reducing LDL cholesterol levels in primary hypercholesterolemia patients.
RCTEffects of high doses of simvastatin and atorvastatin on high-density lipoprotein cholesterol and apolipoprotein A-I.
High doses of simvastatin raise high-density lipoprotein cholesterol and apolipoprotein A-I more than atorvastatin, suggesting differences in metabolic effects on plasma lipids and lipoproteins.
RCTLarge Human TrialHighly CitedA multicenter, double-blind, one-year study comparing safety and efficacy of atorvastatin versus simvastatin in patients with hypercholesterolemia.
Atorvastatin effectively lowers LDL cholesterol and triglycerides more effectively than simvastatin, with 46% of patients achieving target goals by week 16.
RCT